Main Article Content

Abstract

During the past decade, major improvements in the management of Acute Myocardial Infarction (AMI) patients have reduced AMI-related mortality by 50% in developed countries. Specifically, the introduction of intensive care units in the 1960s, improvement in pharmacologic reperfusion in the 1980s, and the widespread availability of percutaneous coronary intervention (PCI) in the 1990s have markedly reduced in-hospital mortality from AMI over the past 15 years [5]. Furthermore, the near-universal acceptance and prompt application of antiplatelet agents, β-adrenergic blockers, angiotensin-converting enzyme (ACE) inhibitors, and statins after an AMI have contributed to the improvement in long-term survival among AMI patients. Still, these great strides cannot diminish the impact of MI. First, the number of at-risk patients (e.g., genetic predisposition, smoking, poor dietary habits, or physical inactivity) is enormous and continues to increase, especially the population of diabetics, elderly patients, and other individuals with metabolic syndrome [5, 6].


One such case with high risk and in need of Coronary Bypass Grafting (CABG) has been treated by Dr. AppaRao’sImmunonutritive therapy and the result was beneficial to the patient. Patient was followed for a year and was found to be healthy.

Keywords

Coronary artery disease Immunonutritive therapy

Article Details

How to Cite
Dr.PeddapalliAppa Rao, Dr. K V Subrahmanyam, Dr. P.Sandhya Rani, & Dr. Smitha Madhuri. (2021). A case report on management of coronary artery disease. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(1), 89-92. https://doi.org/10.61096/ijrpp.v6.iss1.2017.89-92

References

  1. [1]. American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas: American Heart Association, 1998.
  2. [2]. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007, guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116, 2007, 803–877.
  3. [3]. Antman EM, Anbe DT, Armstrong PW, Bates ER, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110, 2004, 588–636.
  4. [4]. American Heart Association. Heart Disease and Stroke Statistics— 2007, Update. Dallas, TX: American Heart Association, 2007.
  5. [5]. Boersma E, Mercado N, Poldermans D, et al. Acute myocardial infarction. Lancet 361, 2003, 847–858.
  6. [6]. Katritsis D, Karvouni E, Webb-Peploe MM. Reperfusion in acute myocardial infarction: current concepts. ProgCardiovasc Dis 45, 2003, 481–492.
  7. [7]. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-risk plaque: Part I. evolving concepts. J Am CollCardiol 46, 2005, 937–954.
  8. [8]. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 111, 2005, 3481–3488.
  9. [9]. Spinler SA. Acute coronary syndromes. In: Dunsworth TS, Richardson MM, Cheng JWM, eds. Pharmacotherapy Self-Assessment Program, Book 1, Cardiology, 6th ed. Kansas City: American College of Clinical Pharmacy, 2007, 59–83.
  10. [10]. Peterson ED, Roe MT, Muglund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295, 2006, 1912–1920.
  11. [11]. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: The American College of Cardiology’s Guidelines Applied in Practice (GAP) Projects in Michigan. J Am CollCardiol 46, 2005, 1242–1248.